0001213900-19-016514.txt : 20190822 0001213900-19-016514.hdr.sgml : 20190822 20190822163033 ACCESSION NUMBER: 0001213900-19-016514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190820 FILED AS OF DATE: 20190822 DATE AS OF CHANGE: 20190822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Juda Scott CENTRAL INDEX KEY: 0001767084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 191046392 MAIL ADDRESS: STREET 1: 325 N. LARCHMONT BLVD, SUITE 375 CITY: LOS ANGELES STATE: CA ZIP: 90004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml X0306 4 2019-08-20 0 0001711754 Inmune Bio, Inc. INMB 0001767084 Juda Scott C/O INMUNE BIO INC., 1200 PROSPECT STREET, SUITE 525 LA JOLLA CA 92037 1 0 0 0 Common Stock 2019-08-20 4 P 0 2500 6.00 A 25000 D Common Stock 2019-08-21 4 P 0 2500 6.00 A 27500 D The Reporting Person purchased 2,500 shares of the Issuer's common stock in an open market transaction on August 20, 2019 and 2,5000 shares of the Issuer's common stock in an open market transaction on August 21, 2019. The Reporting Person's shares are held by Fossick Capital LP ("Fossick"), a limited partnership. The Reporting Person holds all voting and dispositive control over the Issuer's shares of common stock held by Fossick. /s/ Scott Juda 2019-08-22